AMCP Market Insights Summit: New Approaches to the Management of Psoriasis

Webinar Recorded on May 8, 2018 

Click here to download PDF of presentation


In the last 10 years, advances in therapies and approaches to treating moderate to severe psoriasis have gained increasing attention. The newer biologics present unique challenges to some stakeholders, as they do not have the broad indications within the auto-immune category, yet exhibit differentiation in clinical results. In December 2017, a group of clinicians and AMCP members representing health plans, integrated systems, pharmacy benefit managers and employers convened to discuss the clinical data and current approaches to formulary management of psoriasis.

This webinar will provide of summary of their discussions and insights as well as:

  • Provide an high-level overview of clinical efficacy of newer psoriasis products, both current and pipeline
  • Identify formulary and utilization management challenges faced by payers with new therapies
  • Provide webinar attendees with an overview of the Summit discussions and considerations for optimal patient management


  • Terry Richardson, PharmD, BCACP, AMCP Director of Product Development
  • Dana Regan, Consultant and Lead, AMCP Market Insights